CROI 2019 Program and Conference Information

Poster Sessions

565 CLINICAL OUTCOMES IN PERSONS COINFECTEDWITHHIV AND HCV: IMPACT OF HCV TREATMENT Lars Peters, Amanda Mocroft, Jens D. Lundgren, Jan Gerstoft, Line D. Rasmussen, Sanjay Bhagani, Inka Aho, Christian Pradier, Johannes Bogner, Jürgen K. Rockstroh, Cristina Mussini, Adriano Lazzarin, Fernando Maltez, Montse Laguno, Gilles Wandeler, for the EuroSIDA Study INTERFERON-FREE REGIMENS IMPROVE RENAL FUNCTION IN PATIENTSWITH CHRONIC HEPATITIS C Nicola Coppola, Federica Portunato, Antonio Riccardo Buonomo, Laura Staiano, Riccardo Scotto, Biagio Pinchera, Stefania De Pascalis, Salvatore Martini, Mariantonietta Pisaturo, Daniela Caterina Amoruso, Guglielmo Borgia, Carmine Coppola, Ivan Gentile PCSK9 LEVELS DECLINEWITHHCV DIRECT-ACTING ANTIVIRAL THERAPY INHIV/HCV COINFECTION Malini M. Gandhi, Kim-Lien Nguyen, Jordan E. Lake, Diana Liao, Mario Guerrero, Wilbert C. Jordan, Eric Daar, Debika Bhattacharya, Kara W. Chew LIVER STIFFNESS AT SVR PREDICTS HEPATIC COMPLICATIONS IN HCV-INFECTED PATIENTS Anaïs Corma-Gómez, María Iglesias, Francisco Téllez, Luis Morano, Antonio Rivero-Juárez, Maria J. Rios-Villegas, Marta Santos, Francisco Vera, Jesus Santos, Rafael Granados, Dolores Merino, Ignacio d. Santos Gil, Juan Macías, Juan A. Pineda, for the Proyecto GEHEP-011 INFLAMMATION, ARTERIAL STIFFNESS, AND DIRECTLY ACTING ANTIVIRALS INHCV AND HIV/HCV Sonika Malik, Ruchi Bisen, Melissa Osborn, Sanjay Gandhi, Grace A. McComsey, Corrilynn O. Hileman EFFECT OF LIVER FIBROSIS STAGE AND DAA TREATMENT ON RISK OF CVD EVENTS IN ERCHIVES Adeel A. Butt, Peng Yan, Samia Aslam, Obaid S. Shaikh LIVER FIBROSIS HINDERS T-CELL HOMEOSTASIS RESTORATION AFTER HCV ERADICATIONWITH DAAs Beatriz Álvarez, Andrea García, Clara Restrepo, Marcial García, María Ángeles Navarrete, Victoria M. de Santisteban, José Ligos, Alfonso Cabello, Laura Prieto, Sara Nistal, María Montoya, Miguel Górgolas, Norma Rallón, José Miguel Benito IMPACT OF DIRECT-ACTING ANTIVIRALS ON RATES OF HCC IN HCV- AND HIV-INFECTED PATIENTS Taiwo A. Ajose, Michael Flood Poster P-K2 HCV THERAPEUTICS: MOVING FROM TREATING THE PERSON TO TREATING THE POPULATION Poster Hall - 4EF 2:30 PM - 4:00 PM 573 BARRIERS TO INITIATING DAA THERAPY INHCV/HIV COINFECTED PATIENTS Taiwo A. Ajose, Austin Chan 574 PROGRESS TOWARDS HCVMICRO-ELIMINATION IN AN URBAN HIV-INFECTED COHORT Oluwaseun Falade-Nwulia, Catherine Sutcliffe, Shruti H. Mehta, Juhi Moon, Geetanjali Chander, Jeanne C. Keruly, Jennifer Katzianer, Richard D. Moore, Mark Sulkowski 567 568 569 570 571 572

Poster Sessions • Tuesday 566

CROI 2019 76